Literature DB >> 15675665

Thermal ablation of prostate diseases: advantages and limitations.

K Shinohara1.   

Abstract

Both benign and malignant conditions affecting prostate gland are very common in elderly men. However, the conventional treatment of these conditions can be associated with significant side effects and complications, and less invasive treatment alternative has been always searched for. Because of the anatomical location and easy accessibility of prostate, many newer treatment modalities using thermal ablation have been applied to the organ. These include not only heating of the pathological tissue but also freezing. Some of such treatment techniques have shown to be effective and safe and been clinically used widely. In this review article, various tissue ablation techniques using temperature change applied to prostate gland are covered. Each procedure's advantages and disadvantages are compared and discussed.

Entities:  

Mesh:

Year:  2004        PMID: 15675665     DOI: 10.1080/02656730412331286876

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  11 in total

1.  Nanotechnology for energy-based cancer therapies.

Authors:  Kyle Gilstrap; Xiaoxiao Hu; Xiongbin Lu; Xiaoming He
Journal:  Am J Cancer Res       Date:  2011-03-11       Impact factor: 6.166

2.  Referenceless MR thermometry for monitoring thermal ablation in the prostate.

Authors:  Viola Rieke; Adam M Kinsey; Anthony B Ross; William H Nau; Chris J Diederich; Graham Sommer; Kim Butts Pauly
Journal:  IEEE Trans Med Imaging       Date:  2007-06       Impact factor: 10.048

3.  Thermal-Disrupting Interface Mitigates Intercellular Cohesion Loss for Accurate Topical Antibacterial Therapy.

Authors:  Benhui Hu; Christopher Berkey; Timothy Feliciano; Xiaohong Chen; Zhuyun Li; Chao Chen; Shahrouz Amini; Mui Hoon Nai; Qun-Li Lei; Ran Ni; Juan Wang; Wan Ru Leow; Shaowu Pan; Yong-Qiang Li; Pingqiang Cai; Ali Miserez; Shuzhou Li; Chwee Teck Lim; Yun-Long Wu; Teri W Odom; Reinhold H Dauskardt; Xiaodong Chen
Journal:  Adv Mater       Date:  2020-02-19       Impact factor: 30.849

4.  Effective learning strategies for real-time image-guided adaptive control of multiple-source hyperthermia applicators.

Authors:  Kung-Shan Cheng; Mark W Dewhirst; Paul R Stauffer; Shiva Das
Journal:  Med Phys       Date:  2010-03       Impact factor: 4.071

5.  Tumour thermotolerance, a physiological phenomenon involving vessel normalisation.

Authors:  Ruud P M Dings; Melissa L Loren; Yan Zhang; Sterling Mikkelson; Kevin H Mayo; Peter Corry; Robert J Griffin
Journal:  Int J Hyperthermia       Date:  2011-01-04       Impact factor: 3.914

6.  Dynamic Data-Driven Finite Element Models for Laser Treatment of Cancer.

Authors:  J T Oden; K R Diller; C Bajaj; J C Browne; J Hazle; I Babuška; J Bass; L Biduat; L Demkowicz; A Elliott; Y Feng; D Fuentes; S Prudhomme; M N Rylander; R J Stafford; Y Zhang
Journal:  Numer Methods Partial Differ Equ       Date:  2007-04-26       Impact factor: 3.009

7.  A two-state cell damage model under hyperthermic conditions: theory and in vitro experiments.

Authors:  Yusheng Feng; J Tinsley Oden; Marissa Nichole Rylander
Journal:  J Biomech Eng       Date:  2008-08       Impact factor: 2.097

8.  Cell penetrating peptides fused to a thermally targeted biopolymer drug carrier improve the delivery and antitumor efficacy of an acid-sensitive doxorubicin derivative.

Authors:  Leslie Walker; Eddie Perkins; Felix Kratz; Drazen Raucher
Journal:  Int J Pharm       Date:  2012-07-28       Impact factor: 5.875

9.  Temperature-feedback upconversion nanocomposite for accurate photothermal therapy at facile temperature.

Authors:  Xingjun Zhu; Wei Feng; Jian Chang; Yan-Wen Tan; Jiachang Li; Min Chen; Yun Sun; Fuyou Li
Journal:  Nat Commun       Date:  2016-02-04       Impact factor: 14.919

10.  Transurethral Microwave Thermotherapy (TUMT) in the Treatment of Benign Prostatic Hyperplasia: A Preliminary Report.

Authors:  Roger J Ziętek; Zbigniew M Ziętek
Journal:  Med Sci Monit       Date:  2021-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.